RaQualia Pharma Competitors and Similar CompaniesClear all
RaQualia Pharma's competitors and similar companies include Novartis, Hutchison China Meditech, Rigel Pharmaceuticals and Moderna.
 RaQualia Pharma RaQualia Pharma (ラクオリア創薬) is a pharmaceutical company specializing in drug discovery research. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. |  Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. |  Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. | |
Founding Date | Founding Date 2008 | Founding Date 1996 | Founding Date 2000 | Founding Date 1996 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Nagoya, JP HQ | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more | Locations South San Francisco, US HQ | |
Employees | Employees 264% increase | Employees 75,883 | Employees 1,811 | Employees 1633% increase | Employees 5,8004% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.6 b | Valuation ($) 256 m | Valuation ($) 21.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) | Revenue (est.) $294.3m (FY, 2025) | Revenue (est.) $1.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $324.4m (FY, 2025) | Cost of goods $19.6m (FY, 2025) | Cost of goods $868m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $49.8b (FY, 2025) | Gross profit $224.2m (FY, 2025) | Gross profit $274.7m (FY, 2025) | Gross profit $1.1b (FY, 2025) |
Net income | Net income N/A | Net income $14b (FY, 2025) | Net income $435.1m (FY, 2025) | Net income $367m (FY, 2025) | Net income ($2.8b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 100m | Total funding raised $ 130m | Total funding raised $ 1.8b |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyHutchison China Meditech
HQ
Shanghai, CN
Employees
1,811
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View companyRigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View companyModerna
HQ
Cambridge, US
Employees
5,800↑ 4% increase
Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.
View company